跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALAMYCIN 300 LA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ALAMYCIN 300 LA
Authorized
STANDARD
ALAMYCIN 300 LA
NORBROOK LABORATORIES LTD.
🇨🇦 Health Canada
Approval Date
Feb 6, 2026
Approval ID
93add0ded95c1b7b
Company
NORBROOK LABORATORIES LTD.
Type
Standard
Approval Details
Approval Id
93add0ded95c1b7b
Drug Approval Canada Name
ALAMYCIN 300 LA
Product Name
ALAMYCIN 300 LA
Status
Dormant
Status Date
2025-07-08
Original Market Date
2020-11-04
Drug Class
Veterinary
Dosage Form
Solution
Route Of Administration
Intramuscular , Subcutaneous
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0105553004
Company Name
NORBROOK LABORATORIES LTD.
Company Address
Carnbane Industrial Estate Newry Northern Ireland United Kingdom BT35 6QQ
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 6, 2026
Approval ID
93add0ded95c1b7b
Type
Standard
Back to Health Canada Approvals